Company Performance: Revenue growth, profitability, and successful drug development progress positively impact the stock price.

Clinical Trial Results: Positive clinical trial outcomes for BIOT.AT's pipeline products significantly boost investor confidence and share value.

Regulatory Approvals: Approval of drugs by regulatory bodies like the FDA or EMA leads to market access and revenue potential, driving the stock price up.

Market Sentiment: Overall investor optimism or pessimism in the biotechnology sector affects BIOT.AT's stock price.

Competition: Competitor's success or failure in similar therapeutic areas impacts investor perception of BIOT.AT's market share and profitability.

Partnerships & Acquisitions: Strategic collaborations or acquisitions can increase BIOT.AT's value and influence the stock price.

Economic Conditions: Broader economic factors like interest rates and inflation can impact investor risk appetite and therefore biotech stocks.

News & Media Coverage: Positive or negative news reports can significantly affect investor sentiment and trading activity, influencing the stock price.

Analyst Ratings: Recommendations from financial analysts can influence investor decisions and impact the demand for BIOT.AT shares.